iPS細胞生成相關專利的狀況：2011年 是由出版商France Innovation Scientifique et Transfert (FIST SA)在2011年07月所出版的。
這份英文市場調查報告書價格從美金4200起跳。
特定疾病治療的幹細胞治療期待年年提昇、另一方面幹細胞、尤其是人體的胚性幹細胞的使用在社會性、經濟性、科學性尚有很多不確定的因素。對於專利、技術的新舊程度到研究機構成為主要提出意願者、新的企業專利取得也會加入行列。
本報告書內容包括:人工誘導多能性幹細胞（iPS細胞）領域的專利申請狀況的調查分析、500以上的新專利的各種類考察彙整、內容綱要摘記如下:
第1章 概要
- 技術概要：脫分化法
- 技術概要：再程式技術
- 專利相關疑問
第2章 專利提出意願的趨勢和指南
- 專利提出意願的趨勢（1995∼2010年）
- 優先提出意願的趨勢和指南
- 專力延長指南
- 產業/機構的提議
- 提出意願者數的推移
第3章 專利提出意願者分析
- 主要提出意願者的推移（1995∼2010年）
- 最初提出意願者10家所持有的檔案
- 主要機構/產業的提議詳細內容
- 提出意願者的共同提議
- 提出意願者和相關公司
第4章 發明者的分析
第5章 專利意願的主題
第6章 檔案分析（關於各項目、提出意願的狀況和研究機構提出意願者、產業提出意願者、投資家的定位提議）
- 檔案分析
- iPS細胞生成技術
- 載體的種類
- 細胞型的複製起點
- 再程式的細胞型
第7章 引用/延長分析
第8章 許諾/再審查
第9章 結論/附錄
Abstract
Description/Summary
IP Overview presents a patent mapping analysis of the "induced pluripotent
stem cell" field.
Stem cell based therapies raise high hope concerning the treatment of several
human diseases. However, there still exists a great deal of social, economic
and scientific uncertainty surrounding the use of stem cells, especially over
the use of human embryonic stem cells. The recent development of induced
pluripotent stem cells (iPS) bypass some of those critical issues by
developing pluripotent stem cells customized to the patient, easy to produce
and that does not require the use of embryos.
Several techniques have been developed and protected for the production of iPS
cells such as the Thomson' s and Yamanaka' s techniques that have been published
simultaneously. Indeed, since 2005, many new players (mainly institutional
applicants) positioned on the thematic to bring their own brick to this
technology. The setting up of winning patent strategies by existing actors and
potential new entrants requires the ability to navigate accurately through the
current patent landscape.
This patent landscape analysis on the field of "iPS cell generation" shows a
boom of patent filings in this sector since 2007. Due to the youth of the
technology, a majority of patent applications have been filed by institutional
applicants such as the institutes of the historical inventors Shinya Yamanaka
(Kyoto University - 25 filings), James Thomson (University of
Wisconsin-Madison - 2 filings) or Rudolf Jaenisch (Whitehead Biomedical
Institute - 7 filings). However several young companies have positioned
themselves early on the thematic and have tried to set up interesting deals
with well positioned institutional applicants such as iPierian that obtained
non-exclusive worldwide rights from Kyoto University.
In this promising sector driven by potential important markets and where 244
patent families have been filed, this report "IP Overview - iPS Cell
Generation - 2011" provides you with a comprehensive panorama of the
intellectual property landscape and helps you:
- Position your company' s R&D and IP Portfolio
- Identify key inventors and key players involved in the generation of iPS
cells
- Understand the collaboration networks and their dynamics
- Discover new trends and emerging topics
Table of Contents
Generalities
- Brief outline of the technology: dedifferentiation methodologies
- Brief outline of the technology: reprogramming techniques
- Patent query
Evolution and location of patent filings
- Evolution of patent filings (1995-2010)
- Map and evolution of priority filings
- Map of extensions
- Industrial & institutional filings over time
- Evolution of the number of applicants
Analysis of patent applicants
- Main applicants on the entire period (1995-2010)
- Part of the portfolio hold by the first 10 applicants
- Breakdown of filings of the main industrial/institutional applicants over
time
- Main co-filings between applicants
- Applicants and their affiliates
Analysis of inventors
- List of the main inventors
- Main research teams
Topics of patent filings
Breakdown of the portfolio (for each breakdown are presented the evolution of
filings and the positioning of institutional applicants, industrial applicants
and inventors)
- Breakdown of the portfolio
- 1/iPS cell generation techniques
- 2/Types of vector
- 3/Origin of cell types
- 4/Types of cell to be reprogrammed
Citation & Extension Analysis
- List of the most cited patents and patent applications
- List of the most extended patents & patent applications
Granting & Re-examination
- List of granted patents
- Re-examination
Conclusion - Appendices
- Conclusive comments
- Appendix - Applicant focuses
